{"id":52420,"date":"2024-11-04T12:18:26","date_gmt":"2024-11-04T12:18:26","guid":{"rendered":"https:\/\/www.innovationnewsnetwork.com\/?p=52420"},"modified":"2024-11-04T12:18:26","modified_gmt":"2024-11-04T12:18:26","slug":"medsafetyweek-2025-preventing-medicine-side-effects","status":"publish","type":"post","link":"https:\/\/www.innovationnewsnetwork.com\/medsafetyweek-2025-preventing-medicine-side-effects\/52420\/","title":{"rendered":"MedSafetyWeek 2025: Preventing medicine side effects"},"content":{"rendered":"
#MedSafetyWeek is part of international efforts to raise awareness about the importance of reporting suspected medicine side effects to national medicines regulatory authorities, such as the Medicines and Healthcare Products Regulatory Agency (MHRA).<\/p>\n
This year\u2019s campaign, which runs from 4 to 10 November, focuses on correctly using medicines to prevent side effects.<\/p>\n
This means taking the right medicines\u00a0at the right time, in the right way and at the right dose, and carefully following instructions for the\u00a0use of medical devices.<\/p>\n
Following these steps can drastically reduce the risk of side effects and safety issues.<\/p>\n
When medicine side effects do arise, this MedSafetyWeek\u00a0they should be reported directly to the MHRA\u2019s Yellow Card scheme<\/a> and local reporting systems as soon as possible.<\/p>\n Anyone can make a report: patients, parents, carers and healthcare professionals.<\/p>\n In the UK, the MHRA\u2019s Yellow Card scheme is a critical source of information for us as the regulator to monitor the safety of healthcare products once they are on the market.<\/p>\n Importantly, Yellow Card reports can help to identify previously unknown side effects \u2013 or adverse drug reactions (ADRs) \u2013 and provide new safety knowledge to ensure risk is minimised.<\/p>\n Reporting to the scheme allows the MHRA to identify new adverse effects and gain more information about known adverse effects. This helps to improve the safety of medicines and healthcare products for all patients.<\/p>\n Safety concerns about medical devices, blood factors, immunoglobulin products, e-cigarettes, and defective, low-quality, or fake healthcare products should also be reported on the Yellow Card website.<\/p>\n This year\u2019s MedSafetyWeek theme of \u2018preventing side effects\u2019 aligns with the third World Health Organization (WHO) Global Patient Safety Challenge: Medication Without Harm<\/a>.<\/p>\n Preventable medicine side effects contribute significantly to an increasing burden on patients and healthcare services, with studies consistently showing that between one-third and a half may be potentially preventable.<\/p>\n Anticipating and managing side effects is key to reducing this burden and protecting patients from avoidable harm.<\/p>\nProtecting patients from avoidable harm<\/h3>\n
Yellow Card Biobank pilots new trial<\/h3>\n